Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma

E-ISSN： 1873-4286|16|11|1272-1283

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.11, 2010-04, pp. : 1272-1283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting signalling pathways for the treatment of multiple myeloma

By Podar Klaus Hideshima Teru Chauhan Dharminder Anderson Kenneth C

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 359-381

Informa Healthcare

Access to resources Recommend Favorite

Cancer vaccine treatment feasible for paediatric solid tumours

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Imatinib mesilate: new perspectives in the treatment of solid tumours

By Smirne Carlo Carbone Anna Pirisi Mario Bellone Graziella

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 327-340

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3173-3187

Bentham Science Publishers

Access to resources Recommend Favorite